These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 220553)
21. Benzodiazepine receptors in the central nervous system. Skolnick P; Paul SM Int Rev Neurobiol; 1982; 23():103-140. PubMed ID: 6288605 [No Abstract] [Full Text] [Related]
23. [Radioligand analysis of receptors on formed elements in the blood and perspectives for its use in psychiatry]. Zozulja AA; Molcan J; Pacáková E Cesk Psychiatr; 1987 Jun; 83(3):167-72. PubMed ID: 2822263 [No Abstract] [Full Text] [Related]
24. The structure and mechanism of neurotransmitter receptors. Implications for the structure and function of the central nervous system. Strange PG Biochem J; 1988 Jan; 249(2):309-18. PubMed ID: 2893605 [No Abstract] [Full Text] [Related]
25. Multiple CNS receptor interactions of ergot alkaloids: affinity and intrinsic activity analysis in in vitro binding systems. U'Prichard DC Adv Biochem Psychopharmacol; 1980; 23():103-15. PubMed ID: 6249089 [No Abstract] [Full Text] [Related]
26. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease. Anichtchik OV; Peitsaro N; Rinne JO; Kalimo H; Panula P Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035 [TBL] [Abstract][Full Text] [Related]
27. Glycine-receptors in the vertebrate central nervous system. DeFeudis FV Acta Physiol Lat Am; 1977; 27(4):131-45. PubMed ID: 617561 [TBL] [Abstract][Full Text] [Related]
28. Imidazoline binding sites (IBS) profile modulation: key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analogues. Gentili F; Bousquet P; Brasili L; Dontenwill M; Feldman J; Ghelfi F; Giannella M; Piergentili A; Quaglia W; Pigini M J Med Chem; 2003 May; 46(11):2169-76. PubMed ID: 12747788 [TBL] [Abstract][Full Text] [Related]
29. Catecholamines and behavior. Engel J; Carlsson A Curr Dev Psychopharmacol; 1977; 4():1-32. PubMed ID: 23246 [No Abstract] [Full Text] [Related]
30. Characterization of imidazoline receptors by radioligand binding. Hudson AL; Lione LA Methods Mol Biol; 1999; 106():37-47. PubMed ID: 9921498 [No Abstract] [Full Text] [Related]
31. The use of gene-manipulated mice in the validation of receptor binding radiotracer. Eckelman WC Nucl Med Biol; 2003 Nov; 30(8):851-60. PubMed ID: 14698789 [No Abstract] [Full Text] [Related]
32. Methodological aspects on drug receptor binding analysis. Wahlström A Acta Pharmacol Toxicol (Copenh); 1978; 43 Suppl 2():74-8. PubMed ID: 213940 [TBL] [Abstract][Full Text] [Related]
34. Receptor characterization and regulation in intact tissue preparations. Pharmacological implications. Shaw CA; Wilkinson M Biochem Pharmacol; 1994 Mar; 47(7):1109-19. PubMed ID: 8161339 [No Abstract] [Full Text] [Related]
35. 'Optimal' designs for drug, neurotransmitter and hormone receptor assays. Dunn G Stat Med; 1988 Jul; 7(7):805-15. PubMed ID: 2841743 [TBL] [Abstract][Full Text] [Related]
36. Verification of both the sequence and conformational specificity of neurotensin in binding to mast cells. Lazarus LH; Perrin MH; Brown MR; Rivier JE Biochem Biophys Res Commun; 1977 Jun; 76(4):1079-85. PubMed ID: 901462 [No Abstract] [Full Text] [Related]
38. Theoretical considerations for the design and development of a drug: influence of pharmacokinetics and dosage regimen on receptor interactions. Mordenti J; Rescigno A Pharm Res; 1993 May; 10(5):777-82. PubMed ID: 8321845 [No Abstract] [Full Text] [Related]
39. Receptor binding: radiopharmaceutical studies. Spencer RP Int J Rad Appl Instrum B; 1990; 17(1):73-6. PubMed ID: 2407695 [No Abstract] [Full Text] [Related]
40. [Neural mechanism of behavior]. GERARD RW No To Shinkei; 1961 Sep; 13():702-10. PubMed ID: 13897849 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]